E-ISSN 2148-5607
RELATED ARTICLES
Editorial
A new marker for lipid peroxidation: Serum paraoxonase activity in non-alcoholic steatohepatitis
(Turk J Gastroenterol 2005; 16: 119-123)
Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment
(Turk J Gastroenterol 2005; 16: 124-128)
Celiac artery compression syndrome: Report of a case and literature review
(Turk J Gastroenterol 1999; 10: 161-163)
Endoscopic management of chronic pancreatitis: Pancreatic stents
(Turk J Gastroenterol 1999; 10: 361-366)
Acute jejunogastric intussusception
(Turk J Gastroenterol 1999; 10: 424-426)
L-Carnitine therapy in non-alcoholic steatohepatitis
(Turk J Gastroenterol 2000; 11: 196-201)
Acute colonic pseudoobstruction: A rare clinical entity
(Turk J Gastroenterol 2000; 11: 239-243)
The comparison of perendoscopic injection therapy with medical treatment in Forrest’s II ulcers: Pilot study
(Turk J Gastroenterol 2001; 12: 40-44)
Obesity and related parameters of non-alcoholic steatohepatitis
(Turk J Gastroenterol 2002; 13: 71-77)
Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis
(Turk J Gastroenterol 2003; 14: 12-17)
The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis
(Turk J Gastroenterol 2003; 14: 228-233)
Hypovolemia-related gastric tissue damage in the setting of upper gastrointestinal bleeding
(Turk J Gastroenterol 2010; 21: 17-22)
DOI: 10.4318/tjg.2010.0042
Apoptosis in selected liver diseases
(Turk J Gastroenterol 2009; 20: 171-179)
DOI: 10.4318/tjg.2009.0003
Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome
(Turk J Gastroenterol 2010; 21: 411-415)
DOI: 10.4318/tjg.2010.0128
Review
Apoptosis and fibrosis in non-alcoholic fatty liver disease
(Turk J Gastroenterol 2005; 16: 1-6)
Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management
(Turk J Gastroenterol 2014; 25: 127-132)
DOI: 10.5152/tjg.2014.7675
Original Article
A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis
(Turk J Gastroenterol 2014; 25: 167-175)
DOI: 10.5152/tjg.2014.5121
The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters
(Turk J Gastroenterol 2015; 26: 408-416)
DOI: 10.5152/tjg.2015.6336
Letter to the Editor
What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?
(Turk J Gastroenterol 2010; 21: 107-112)
DOI: 10.4318/tjg.2010.0066
Liver - Original Article
Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis
(Turk J Gastroenterol 2017; 28: 361-369)
DOI: 10.5152/tjg.2017.17033
Poster Presentation
Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma. A single center experience in western Turkey
(Turk J Gastroenterol 2019; 30: 103-105)
DOI: 10.5152/tjg.2019.68
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 30.05.2019